[KongchangAI]
Unverified75% confidenceSolutionTime unknown

复合配方中'白藜芦醇+NMN'是当前抗衰组合的常见入口方案:白藜芦醇作为Sirtuin通路激活剂需与NAD+前体(NMN/NR)协同才更有理论意义,单独补白藜芦醇追求'长寿'效果证据不足

1
Sources
75%
Confidence
Medium-term (~90 days)
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/204492
API
curl https://kongchang.com/api/v1/knowledge/claims/204492
MCP
get_claim(id=204492)